• Contact Us
  • IND: (+91) 40-485-49062
  • USA: (+1) 614-588-8538

Lipid Panel Test Market: By Disease (Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease), By End-User (Home Based Testing Kits, Diagnostic Laboratories, Hospital) & By Region - Forecast(2018 - 2023)

Report Code : HCR 0314 Format Type: PDF+ Excel Database Client Rating (5/5)
5 Copies Sold

Lipid profile test (LPT), or total lipid profile or lipid panel

is a panel of blood tests that serves as an initial broad medical screening tool for abnormalities in lipids, such as cholesterol and triglycerides. This test enables diagnosis of lipid disorders along with risk for coronary heart disease. There is a high correlation between coronary heart diseases (CHD) with abnormal lipid levels. These tests provides value for serum lipids such as total cholesterol, TG, HDL cholesterol, and VLDL. LPT market includes diagnostic services along with equipment and consumables such as analyzers, integrated systems, and lipid profile cassettes. The results of this test can identify certain genetic diseases and can determine approximate risks for cardiovascular disease, certain forms of pancreatitis, and other diseases. Globally increasing cases of  dyslipidemia, cardiovascular diseases, and hypertension is expected to drive the demand for lipid profile tests during the period of s tudy.

 Lipid Panel Test Market

Geographically North America dominated

global lipid panel test market

driven by best in the class healthcare infrastructure, advanced facilities and awareness and openness amongst citizens towards the availability of the treatment and higher spending by citizens on the healthcare. North America was followed by Europe and Asia-Pacific as second and third largest market for lipid panel test market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.

This report identifies the global lipid panel test market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lipid panel test market.

This report segments global lipid panel test market on the basis of disease, end-user and regional market as follows:


  • Lipid Panel Test Market, By Disease: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease
  • Lipid Panel Test Market, By End-User: Home Based Testing Kits, Diagnostic Laboratories, Hospital)
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the lipid panel test market. Some of the major companies’ profiles in detail are as follows:


  • Abbott Laboratories
  • Avanti Polar Lipids, Inc.
  • Beckman Coulter, Inc.
  • EuroMedixPOC nv/sa
  • F. Hoffmann-La Roche Ltd

PLEASE SELECT LICENCE

Need Assistance?

If you have any questions please contact.

Call Us

(U.S. - Canada toll free)
+1-614-588-8538

Write to Us

(Please send an Email)
[email protected]

Request Sample Data